Sources | Names Used |
---|---|
CTRPv2 | BRD-K04800985 |
PharmacoGx | BRD-K04800985 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF220 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | C17orf50 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | DBI | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | LCP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | MRPL35 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | GS1-393G12.13 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | SMG5 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | MS4A2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | RP11-834C11.12 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | PPP4R3B | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |